Why ImmunityBio Stock Is Soaring Today
The Motley Fool
by newsfeedback@fool.com (James Brumley)February 18, 2026
The biopharma outfit's flagship cancer-fighting drug continues to rack up approvals.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/18/2026